Notably, studies have reported reduced adiponectin levels in LBW subjects [8,11–13], which therefore may contribute to insulin resistance, ectopic fat deposition, metabolic dysfunction-associated steatotic liver disease (MASLD), and eventually overt T2D in these individuals [10,8,14]. Here, ADIPOQ is linked to type 2 diabetes mellitus.